| INTRODUCTION
The SHANK3 (SH3 and multiple ankyrin repeat domains 3) gene encodes a scaffold protein of the postsynaptic density (PSD) of excitatory synapses, functioning by interacting directly or indirectly with various proteins, including major types of glutamate receptors such as NMDARs, AMPARs, and mGluRs (Ehlers, 1999; Sheng & Kim, 2000) . It is preferentially expressed in the striatum, cerebral cortex and cerebellum. SHANK3 belongs to the SHANK family of proteins which contain five conserved protein domains-an ankyrin repeat (ANK), a Src homology 3 (SH3), a PSD-95/Discs large/ZO-1 (PDZ), a prolinerich region containing homer-and cortactin-binding sites (Pro), and a sterile alpha motif (SAM). The homer-and cortactin-binding sites and sterile alpha motif are at the C-terminus of the SHANK3 protein.
Functional studies have demonstrated that these domains are crucial for synaptic targeting and postsynaptic assembly of SHANK3 multimers (Boeckers et al., 2005) .
SHANK3 locates within the 22q13.3 deletion syndrome critical region and is recognized as the disease gene responsible for the major neurological symptoms in Phelan-McDermid syndrome (PHMDS, MIM 606232) including intellectual disability, autistic behavior, absent to delayed speech, and motor delays (Wilson et al., 2003) . Patients with SHANK3 deletions and frameshift mutations have speech or developmental delay with variable severity among different types of mutations. Mutations in the SHANK3 gene were identified in ∼1-2% of patients with autism spectrum disorder (ASD) and up to 2.12% of the cases with moderate to profound intellectual disability (Boccuto et al., 2013; Leblond et al., 2014; Mongan et al., 2002) . SHANK3 mutations were also reported in patients with childhood-onset schizophrenia (Gauthier et al., 2010) .
Herein, we report the first double mutant SHANK3 allele identified by whole exome sequencing (WES), in a patient with autism, intellectual disability, ataxia, dysmorphic features, short stature, progressive spasticity, and microcephaly.
| METHODS

| Whole exome sequencing (WES)
WES was performed and the data were analyzed as described previously (Yang et al., 2013 (Yang et al., , 2014 . The Exome was captured using in-solution exome capture reagent VCRome, version 2.1 (Roche NimbleGen, Madison, WI), and 100-bp paired-end sequencing was performed on Illumina HiSeq 2000 platform. Uniquely aligned sequence was 11.6 Gb with an average coverage of 145 times for the targeted region, and 98.26% of targeted coding bases of the exome were covered by at least 20 reads. WES was performed on the proband only and Sanger sequencing analysis was performed on the proand and the parents for inheritance of the variants related to the proband's phenotypes.
| PCR amplification of the SHANK3 variants, cloning, and sequencing of PCR product
Amplification of genomic DNA from the patient and parents was performed on DNA from peripheral blood to amplify a 473 bp segment covering both variants identified in the patient using primers: forward 5′-CTC TTC GCT CCG TCC AAG-3′ and reverse 5′-GTG AGT GGG TGG ATG AAG GT-3′. PCR was performed using TaKaRa LA Taq DNA polymerase (Takara Bio, Otsu, Japan) with 250 ng of genomic DNA in a reaction with final volume of 50 µL. Betaine was added at final concentration of 1 M. After first round of denaturing at 95°C for 5 min, 36 cycles amplification was performed using the conditions of denaturing 98°C for 10 sec, annealing 62°C for 30 sec, and extension 68°C for 3 min. A final extension was performed at 68°C for 10 min.
The PCR product from the proband was TA cloned (pGEM-T easy, Promega, Madison, WI) and individual clones were analyzed by Sanger sequencing to determine the phase of the two mutations.
| Next generation sequencing (NGS) of PCR products
PCR products from the proband and both parents were fragmented by sonication and indexed for the subsequent NGS analysis by high throughput sequencing on MiSeq (Illumina Inc., San Diego, CA) with 2 × 100 paired-end reads. The raw data in base call files (.bcl format) were converted and demultiplexed by MiSeq (Illumina). Demultiplexed sequence reads were aligned to the human genome 19 (hg19) reference sequence. NGS data were visualized using integrative genomics viewer (IGV) with the setting of paired-end (PE) alignments.
NGS was also performed directly on PCR product from the proband with adaptors added at both ends by two rounds of PCR. Fifteen cycles were performed for the 1st round PCR using primers P1-F 5′-ACA CGA CGC TCT TCC GAT C CTC TTC GCT CCG TCC AAG-′ and P1-R 5′-ACG TGT GCT CTT CCG ATC TGT GAG TGG GTG GAT GAA GGT-3′ and 30 cycles for the 2nd round PCR to add adaptors using primers DAN-I5-D501 5′-AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT ATA GCC TAC ACT CTT TCC CTA CAC GAC GCT CTT CCG ATC-3′
and DAN-I7-D712 5′-CAA GCA GAA GAC GGC ATA CGA GAT CTA TCG CTG TGA CTG GAG TTC AGA CGT GTG CTC TTC CGA TCT-3′.
| CLINICAL REPORT
The proband was a 14-year-old boy of European descent with microcephaly, ataxia, moderate intellectual disability, and dysmorphic features. The mother has a history of infertility and the proband was conceived by in vitro fertilization. He was delivered prematurely at 29 6/7 weeks gestation by C-section to his 35-year-old mother and 32-year-old father. He was born a fraternal triplet to his co-triplets who are identical to each other. The pregnancy was complicated by preeclampsia. Birth weight was 0.845 kg, length 34 cm, head circumstance 24 cm. His Apgar scores were four and seven. He was intubated twice for respiratory distress and also had a PDA that required Indocin for closure. Surgery was required for bilateral inguinal hernias. He was hospitalized for about 3 months before going home. His development was delayed; he did not walk until he was 2½ years old. He had stereotypical behaviors such as spinning toys and repeatedly opening and closing the cabinets. Developmental progression was slow but there was no regression.
Upon physical exam at 13 years of age, his height was 150.1 cm (22nd percentile), weight 38.1 kg (14th percentile), head circumference 50.5 cm (1st percentile, −2.5 SD). He had long nasal columella and slightly thick lips with wide smile but noted family resemblance.
Extremity exam revealed mild bilateral 5th figure clinodactyly, bilateral high arched feet with mild inward curving, bilateral mild overlapping of 2nd toe over 3rd and hunched over posture. He had moderate intellectual disability and autism. His gait examination was notable for ability to walk for short distances but requiring a wheelchair for longer distances due to spasticity. He could feed himself with his fingers and was able to use a spoon. He had hypertonia of his lower extremities, facial hypotonia, and difficulty with coordination of eating. For language, he was only able to babble and communicated with simple augmentative communication software, hand guiding, and directing caregivers to what he wanted. He exhibited aggressive and selfstimulatory behaviors such as hitting himself. There was concern for lower extremity neuropathy due to a severe foot deformity and gait disturbance; however, follow-up electromyogram and nerve conductive velocity were normal. A gastrostomy-tube was present that was primarily used for medications and fluids supplementation. His parents had never observed seizures. He had chronic constipation and poor gut motility.
Family history revealed a female maternal cousin with attention deficit hyperactivity disorder, math learning disability, and a concern for autism spectrum disorder. Both parents and two triplet brothers were generally healthy.
The proband had a normal karyotype, microarray (Agilent 108k), UBE3A sequencing and testing for congenital disorders of glycosylation (affinity chromatography/MS), plasma amino acids and plasma organic acids. Brain MRI at 6.5 years of age was normal. An MRI of the spinal cord was performed due to his progressive lower extremity spasticity and revealed a tethered cord which was surgically released.
| RESULTS
Whole Exome Sequencing (Baylor Genetics Laboratories) was ultimately pursued and revealed a heterozygous c.2860dupC (p. To avoid any potential artifacts introduced by fragmentation of PCR products in library construction, NGS was also performed directly on PCR products without fragmentation. 893k matched paired-end reads with expected gap distance, out of total 1.17 million reads, were obtained. Randomly selected PE reads with sequences covering both SHANK3 variant sites were analyzed. 84% (47/56) PE reads with at least one mutation showed in cis configuration (Figure 2 ), which is much higher than that observed in NGS data on the fragmented PCR product.
To further confirm the in cis configuration, the PCR product from the proband was cloned and 10 individual clones were subsequently Sanger sequenced. Sequence analysis of all the clones consistently showed that the c.2860dupC and c.3236C>T were on the same allele of SHANK3 (Figure 3 ).
| DISCUSSION
We identified two de novo SHANK3 variants, including a truncating mutation and a missense change, in a boy with intellectual disability and autism. Both variants were within exon 21 on a single allele with the truncating mutation 376 bp upstream of the missense change. Double de novo single nucleotide germline mutations in the same gene have been reported in only a few genes. Two de novo mutations in fibrillin (FBN1), c.T3212G, and c.A3219T, were reported in a patient with neonatal Marfan syndrome (Wang et al., 1996) . A de novo double missense mutant allele in RET in a patient with MEN2A, c.634T>C, and c.640C>G, was reported (Tessitore et al., 1999) . Two de novo missense changes, c.2930C>G, and c.2955T>C, in the androgen receptor gene located on the X chromosome were reported in monozygotic twins diagnosed with complete androgen insensitivity syndrome (Mongan et al., 2002) . All these aforementioned changes are in a single allele within fourteen bases of each other. The distance of the two de novo SHANK3 mutations in this patient is farther away than these previously reported double mutations in a single allele. These spontaneous multiple changes in close proximity on the same allele are consistent with hypermutability mediated by nucleotide pool imbalances or a transient hypermutagenic conformation of a normally high fidelity polymerase (Drake, 2007) . Transient error-prone conditions may cause so called "mutation showers," clusters of closely spaced mutations (Wang et al., 2007) . It is unknown whether there are de novo changes in addition to the two SHANK3 mutations since inheritance was studied only on the variants relevant to the proband's phenotypes. 
Individuals with SHANK3 truncating mutations in exon 21
displayed autism and moderate to severe/profound intellectual disability (Leblond et al., 2014) . Our patient had moderate intellectual disability and autism, global developmental delay, and hypotonia, which have been consistently observed in patients with SHANK3 truncating mutations. In addition, our patient also showed features that have been previously reported in a subset of patients, including microcephaly, feeding difficulty, ataxia, and constipation. Epilepsy and regression, which have been observed in patients with SHANK3 haploinsufficiency, were not present. In general the clinical presentation of our patient was consistent with the clinical features in patients with SHANK3 truncating mutations.
The c.2860dupC truncating mutation is expected to cause a frameshift and a premature stop codon at position 954, leading to the loss of critical protein interaction domains (Homer, Abpl, cortactin) in the C-terminal region of SHANK3. The mutation is in the penultimate exon, more than 1.7 kb upstream of the last splice donor site. The mutant mRNA is expected to escape non-sense mediated decay according to "55-bp rule." Truncating mutations are enriched in the exon 21 (Leblond et al., 2014) . Multiple functional studies have been performed on mutations in exon 21 resulting in truncating proteins without C-terminal critical domains. A similar frameshift mutation, c.2497dupG, resulted in the truncated protein accumulating in the nucleus of transfected cells and the cells had reduced complexity of the dendritic tree, less spines, and fewer excitatory synapses (Cochoy et al., 2015) . Another similar frameshift mutation, causing a premature stop codon at position 1227, strongly affected spine development and morphology, as well as growth cone motility (Durand et al., 2012) .
The missense change, c.3236C>T (p.P1079L), is in the same exon and only 125 amino acids downstream of the truncating mutation. The proline at position 1,079 is a moderately conserved amino acid (considering 12 species) and this variant was predicted to be tolerable by SIFT (http://sift.jcvi.org/) and benign by Polyphen-2 (http://genetics. bwh.harvard.edu/pph2/). A scaled combined annotation-dependent depletion (CADD) score is 23, which means that this missense change is predicted to be amongst the top 1% of deleterious variants in the human genome. It is inconclusive for the pathogenicity of this change with conflicting predicted results, not to mention that extreme caution must be taken for in silico analysis programs (Miosge et al., 2015) . Since the two changes are on the same allele, the functional effect of the However, SHANK3 contains multiple intragenic promoters and alternative splicing (Maunakea et al., 2010 ). An extensive array of mRNA and protein isoforms has been identified, but the complex transcriptional regulation of SHANK3 is incompletely understood (Waga et al., 2014) . Therefore, the contribution to our patient's phenotype from this missense change cannot be completely ruled out.
Previously described methods for determining the phase of two changes in one gene include testing parents or relatives, restriction enzyme digestion, allele specific PCR, sequencing of cloned PCR products and digital PCR followed by DNA sequencing. Massively parallel sequencing has also been used for phase determination through mate-pair sequencing of a segment enriched by long range amplification (Cradic et al., 2014) . The relationship between two alleles was established by comparing the base calls at each heterozygous position in fragments covering both heterozygous positions with the pairs of sequence reads. A small percentage of incorrectly linked bases have also been observed, with recombination events during PCR amplification were the most common source of error, accounting for 7% of total reads. Other factors, such as random error in NGS data and ligation of fragments from opposite alleles during mate pair library preparation, may also be attributed to error. Our NGS sequencing revealed that majority of PE reads have both SHANK3 mutations indicating a cis configuration. A small percentage of PE reads with a mutation in one position and a reference allele in the other position were observed in this study, mainly due to in vitro recombination during PCR, possibly through incomplete PCR products as primers. In comparison with the NGS data generated after fragmentation of PCR products, the NGS data generated without fragmentation have much higher rate of PE reads within expected gap distance over total reads (75% vs. 4%). The percentage of incorrectly linked bases is much lower in NGS data generated directly from PCR amplification without fragmentation than those with fragmented PCR products. Our study demonstrated that direct NGS sequencing of a PCR product with adaptors added during amplification represents a simple tool for gene phasing.
In summary, for the first time, we identified two de novo mutations in one SHANK3 allele in a patient. Considering the phase and FIGURE 2 Representatives PE reads from Next-generation sequencing (NGS) demonstrate the two SHANK3 variants are on the same allele. A total of 84% of PE reads with at least one mutation in cis configuration. Each horizontal bar stands for one paired-end read with the gray thick bars representing sequences same as reference sequences. The purple bar indicates the c.2860dupC variant and the red bar indicates the c.3236C>T variant. The few PE reads with only one mutation detected, which were most likely generated from recombination during PCR, are indicated by blue arrows. [Color figure can be viewed at wileyonlinelibrary.com] characteristics of the two variants, the clinical features in this individual are most likely the consequence of the truncating mutation with no or minimum contribution from the missense change.
